Lower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer

[ad_1]

(MedPage Today) — CHICAGO — For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose — and safer, the API-CAT randomized trial…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/acc/114876

Author :

Publish date : 2025-03-29 14:30:00

Copyright for syndicated content belongs to the linked Source.